Abstract
Mentally healthy subjects show increased plasma concentrations of the neuropeptides, arginine vasopressin (AVP) and oxytocin (OT), under conditions of stress, but data are lacking about plasma concentrations of AVP and OT in patients with major depression. We thus assessed plasma concentrations of AVP and OT in patients with major depression (n = 52) and healthy controls (n = 37). Mean plasma AVP concentrations were higher in the group of depressed patients than in controls. A subgroup of 16 patients showed very high levels of plasma AVP, but no other feature differentiating this subgroup from the other patients was found. In-patients showed higher plasma AVP levels than out-patients, and melancholic patients had higher plasma AVP levels than did nonmelancholic patients. Plasma AVP levels were slightly related to psychomotor retardation and significantly inversely to neuroticism. Patients' plasma OT concentrations had a wider range than in controls. AVP and AVP-mediated functions may be a factor in the clinical picture of depression, possibly by influencing the activity of the hypothalamic-pituitary-adrenal axis. © 1997 American College of Neuropsyphopharmacology
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Londen, L., Goekoop, J., van Kempen, G. et al. Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression. Neuropsychopharmacol 17, 284–292 (1997). https://doi.org/10.1016/S0893-133X(97)00054-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/S0893-133X(97)00054-7
Keywords
This article is cited by
-
Psychological symptoms and brain activity alterations in women with PCOS and their relation to the reduced quality of life: a narrative review
Journal of Endocrinological Investigation (2024)
-
Detection, processing and reinforcement of social cues: regulation by the oxytocin system
Nature Reviews Neuroscience (2023)
-
Relationship between postpartum depression and plasma vasopressin level at 6–8 weeks postpartum: a cross-sectional study
Scientific Reports (2023)
-
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Reproductive Sciences (2023)
-
Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis
Cell Research (2022)